Wavefront Analyzes and Visual Performance of Three Multifocal Intra-ocular Lenses
IOL
Phase 1 Study of Ocular Aberrations and Visual Performance of Eyes Implanted With Three Multifocal Intra-ocular Lenses
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to determine if differences in the design of multifocal intra-ocular lenses would mean different values of higher-order aberrations and different performance in objective parameters such as modulation transfer function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Mar 2009
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 3, 2009
CompletedFirst Posted
Study publicly available on registry
April 7, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedJuly 2, 2010
April 1, 2009
8 months
April 3, 2009
July 1, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual acuity, wavefront data and modulation transfer function
30, 90 and 120 days after surgery
Secondary Outcomes (1)
contrast sensitivity
90 days after surgery
Study Arms (3)
Tecnis
ACTIVE COMPARATORReSTOR
ACTIVE COMPARATORReZoom
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients with bilateral visually significant cataract with corneal astigmatism lower than 1.0D
You may not qualify if:
- Any ocular diseases, such as:
- corneal opacities or irregularity
- dry eye
- amblyopia
- anisometropia
- glaucoma
- retinal abnormality
- Surgical complications
- IOL tilt
- IOL decentration greater than 0.4 mm (estimated by retroillumination)
- Incomplete follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of São Paulo
São Paulo, São Paulo, 05403-000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 3, 2009
First Posted
April 7, 2009
Study Start
March 1, 2009
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
July 2, 2010
Record last verified: 2009-04